Deciphering cellular states of innate tumor drug responses.
about
A functional and regulatory network associated with PIP expression in human breast cancerSystems medicine: the future of medical genomics and healthcareNONO and RALY proteins are required for YB-1 oxaliplatin induced resistance in colon adenocarcinoma cell linesHsp60 regulation of tumor cell apoptosisThe atypical histone macroH2A1.2 interacts with HER-2 protein in cancer cellsDysadherin: a new player in cancer progressionICAM-1 suppresses tumor metastasis by inhibiting macrophage M2 polarization through blockade of efferocytosis.Molecular signature of cancer at gene level or pathway level? Case studies of colorectal cancer and prostate cancer microarray data.Integrating Colon Cancer Microarray Data: Associating Locus-Specific Methylation Groups to Gene Expression-Based Classifications.Common human cancer genes discovered by integrated gene-expression analysis.Systemic endocrine instigation of indolent tumor growth requires osteopontin.Characterisation and correction of signal fluctuations in successive acquisitions of microarray images.Presence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancer.Global analysis of extracytoplasmic stress signaling in Escherichia coli.Gene expression profiling and real-time PCR analyses identify novel potential cancer-testis antigens in multiple myeloma.Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment.Meta-analysis of multiple microarray datasets reveals a common gene signature of metastasis in solid tumors.Positive outcomes of oil palm phenolics on degenerative diseases in animal modelsSubnetwork state functions define dysregulated subnetworks in cancer.Gene signatures of drug resistance predict patient survival in colorectal cancerReptin regulates DNA double strand breaks repair in human hepatocellular carcinoma.Molecular concepts analysis links tumors, pathways, mechanisms, and drugsIdentification of galanin and its receptor GalR1 as novel determinants of resistance to chemotherapy and potential biomarkers in colorectal cancerSUN2 exerts tumor suppressor functions by suppressing the Warburg effect in lung cancerExpression profile of innate immune receptors, NLRs and AIM2, in human colorectal cancer: correlation with cancer stages and inflammasome componentsThe estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome.Tumor suppressive role of sestrin2 during colitis and colon carcinogenesis.Polyisoprenylated methylated protein methyl esterase is both sensitive to curcumin and overexpressed in colorectal cancer: implications for chemoprevention and treatment.A colorectal cancer classification system that associates cellular phenotype and responses to therapyDICER1 and PRKRA in Colon Adenocarcinoma.TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway.Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition.Mutations in the Saccharomyces cerevisiae kinase Cbk1p lead to a fertility defect that can be suppressed by the absence of Brr1p or Mpt5p (Puf5p), proteins involved in RNA metabolism.Tissue inhibitor of metalloproteinase 1 expression associated with gene demethylation confers anoikis resistance in early phases of melanocyte malignant transformationFOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis.A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor.Midkine confers Adriamycin resistance in human gastric cancer cells.Dysadherin expression promotes the motility and survival of human breast cancer cells by AKT activation.Proteomic characterization of peroxisome proliferator-activated receptor-γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype.
P2860
Q21143857-ACF73FF8-2355-45E2-A5CD-65A542C04601Q24288895-6A262C07-3249-4CAA-A76D-06EAF36346E3Q24298410-A96A65AA-DDF8-4C90-8FAF-242A6246BA8BQ24303954-A8D5C275-40EA-44D2-A0CD-84FE74D84323Q24322930-0A2A7583-2DA5-45E3-AC8A-1BBF3D915AFBQ24671729-3C06A0B2-F7CF-40EA-B9B9-0DC80E65F1CBQ27330207-9624E233-E11F-491F-8D2A-2A5C0DCE6FA3Q30588294-89C7C09E-FEC9-4211-AC7A-2A1ADD6922E4Q31127007-5E668C0B-4DB3-4340-BA2F-F1D7B68E56B6Q33305350-4EC20D10-C5ED-4726-9EF9-EAC7FFD61490Q33343851-350CCE68-6B76-4ED7-ABCF-EA324B246DDEQ33424047-DAE98C3E-8344-459C-8C4F-85ED59EA83DBQ33493198-AD866398-1486-4BDF-B5D0-E0C01A770099Q33504535-2C8FE009-4851-4B26-B09B-6CB90B541C9FQ33691683-2B7A12AA-2A8B-42F6-BEB6-6F3501B6FD20Q33757944-DAE2C567-8728-436B-BB8F-025EB9F41EB0Q33953926-B2DC299D-4F55-4155-A3F2-137320C08036Q34264552-B204A302-1C5B-4F26-A8A4-07A8B295B1AFQ35070492-04298015-0F28-4F63-84CD-951A4BD54676Q35237150-020837DE-710F-44E7-8BAF-3A5664079970Q35602295-D428D565-656E-4CDB-821D-2FFE1E0E1488Q35812701-7094C66B-74B8-4909-80FC-F879A84BD6FCQ36295263-32F14872-5477-4917-BF4B-3C077029D0D2Q36360734-F5120018-F689-4AAA-944C-51D45571EBCEQ36545181-A996EDFC-20D4-4A3F-A176-EA1CB083AE5BQ36678674-033A0696-8E37-4932-B77A-E66EE7FAE5CEQ36723450-F2B758B0-79AD-4087-9F4A-78B24FA7BA1BQ37018902-088954E6-5166-454E-8A93-3260A04135C4Q37175913-58C47FD0-1034-446D-9E80-6A17351A982AQ37207361-AA4F7889-A7CB-4133-AB7E-ED227FB8AAF9Q37267647-86A51F90-83D6-40B7-9442-A890D9620722Q37328450-66C89679-FAF4-4DB5-8F20-0AA72D20203FQ37351784-A1791CF5-0336-44B8-8AAD-A037B84F432DQ37429861-83F63540-E75B-46A7-AED4-D26818DF9E24Q37702756-49CE3E38-E4E2-4371-B1FA-B826F8E76116Q38019814-BFFE0353-59E2-4984-AE8A-2D922B699177Q38279200-46F1ED12-C6A8-4920-8F24-08B9F7B6C4F6Q39350211-1743A11A-34EC-4F64-9E77-B8DCA729A203Q39365972-81681F45-C7B8-4213-9795-94CE586F4E3CQ39514941-8CDC2AFA-E2FE-4403-93DE-614FD412DC18
P2860
Deciphering cellular states of innate tumor drug responses.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Deciphering cellular states of innate tumor drug responses.
@ast
Deciphering cellular states of innate tumor drug responses.
@en
type
label
Deciphering cellular states of innate tumor drug responses.
@ast
Deciphering cellular states of innate tumor drug responses.
@en
prefLabel
Deciphering cellular states of innate tumor drug responses.
@ast
Deciphering cellular states of innate tumor drug responses.
@en
P2093
P2860
P356
P1433
P1476
Deciphering cellular states of innate tumor drug responses
@en
P2093
Charles Auffray
Christine Couillault
Cindy Mollard
Dominique Piatier-Tonneau
Eric Eveno
Esther Graudens
Guilaine Grémy
Malika Lajémi
Patrick Zaborski
Régine Mariage-Samson
P2860
P2888
P356
10.1186/GB-2006-7-3-R19
P577
2006-03-15T00:00:00Z
P5875
P6179
1026127042